isophosphamide mustard has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, TH; Dykes, DJ; Struck, RF; Suling, WJ; Trader, MW | 1 |
| Hansen, L; Harland, SJ; Hartley, JM; Nicholson, PW; Pasini, F; Souhami, RL | 1 |
2 other study(ies) available for isophosphamide mustard and Adenocarcinoma
| Article | Year |
|---|---|
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide; Female; Ifosfamide; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental; Phosphoramide Mustards; Rats; Sarcoma, Yoshida | 1983 |
Metabolism of ifosfamide during a 3 day infusion.
Topics: Adenocarcinoma; Chromatography, Thin Layer; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Osteosarcoma; Phosphoramide Mustards; Rhabdomyosarcoma; Sarcoma, Ewing; Time Factors | 1994 |